Article
Conditional inactivation of FGF receptor 2 reveals an essential role for FGF signaling in the regulation of osteoblast function and bone growth.
Development (Cambridge, England) - 1 Jul 2003
Yu Kai, Xu Jingsong, Liu Zhonghao, Sosic Drazen, Shao Jiansu, Olson Eric N, Towler Dwight A, Ornitz David M
Abstract excerpt
Human craniosynostosis syndromes, resulting from activating or neomorphic mutations in fibroblast growth factor receptor 2 (FGFR2), underscore an essential role for FGFR2 signaling in skeletal development. Embryos harboring homozygous null mutations in FGFR2 die prior to skeletogenesis. To address the role of FGFR2 in normal bone development, a conditional gene deletion approach was adopted. Homologous...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
